AfterPullback: Biotech Stocks

AfterPullback: Biotech Stocks

“AfterPullback: Biotech Stocks” delivers a comprehensive overview of leading U.S.-traded biotech companies, along with emerging and innovative firms that have recently entered the public market. Our selection spans a variety of sectors within biotech, including gene editing, diagnostics, pharmaceuticals, immunotherapy, cancer treatment, regenerative medicine, and bioinformatics.

6 Symbols in watchlist.

SymbolPriceChange %Market CapVolume
MRNA $33.32 -1.45% $14.18B 6,295,489
PACB $1.27 2.42% $378.47M 3,799,099
BNTX $112.46 8.66% $24.88B 2,052,692
FLGT $21.95 -0.14% $672.79M 179,874
CRSP $54.86 4.02% $4.82B 2,736,468
ILMN $98.93 1.28% $15.21B 1,520,132
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.